Media release – Microbio

Microbio Pty Ltd, an Australian-owned biotech company has been awarded a Federal Government Accelerating Commercialisation Grant to commercialise Microbio’s InfectID-Blood Stream Infection (BSI) diagnostic assay. Read more in the full media release.

201123_Microbio_Release_CA_Grant_Success Download

Microbio has developed a new type of COVID-19 test that has the potential to determine not only if someone has the virus but also if they are infectious.

Microbio today announced its ground-breaking InfectID-COVID-19-R test which has been independently validated to identify the presence of replication-competent SARS-CoV-2 virus in samples in 45 minutes (post RNA extraction).

The full press kit and accompanying photographs can be found in this dropbox.

201021_Microbio_Release_Replicating_SARS-CoV-2_test Download

Register your interest

InfectID is evolving rapidly. Fill in the form to keep up with product developments, including the release of Microbio's COVID-19 replicating virus assay.

I am a:
- Pathologist
- Clinician
- Researcher
- Investor
- Product user
- Other
Name
Email
Title
Employer or organisation
Product users: request supporting documents here
- Select All
- Instructions for Use (InfectID-COVID-19) - RotorgeneQ
- Instructions for Use (InfectID-COVID-19) - BMS Mic
Area of interest
Comments
This field is for validation purposes and should be left unchanged.